請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/70480
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳明汝(Ming-Ju Chen) | |
dc.contributor.author | Tsu-Ting Teng | en |
dc.contributor.author | 滕祖廷 | zh_TW |
dc.date.accessioned | 2021-06-17T04:29:07Z | - |
dc.date.available | 2028-08-13 | |
dc.date.copyright | 2018-08-17 | |
dc.date.issued | 2018 | |
dc.date.submitted | 2018-08-13 | |
dc.identifier.citation | 林慶文。2008。乳品加工學,第63-66頁、第106-116頁、第128頁。華香園出版社,民國九十七年十月三版四刷,台北市。
張勝善。1983。牛乳與乳製品,第26-29頁、第36頁、第51頁、第224-225頁、第297-299頁。長河出版社,台北市。 曹博宏、吳輔祐、徐濟泰。2002a。影響羊乳過敏介質分解酵素 (PAF-AH) 活性之研究。中國畜牧學會會誌31(4): 215。 曹博宏、吳輔祐、陳盈吟、黃凱郁、李昱慧。2002b。羊乳血小板活化因子乙醯水解酵素 (PAF-AH) 之特性研究。中國農業化學會會誌 (suppl):C12,62。 傅幼敏、何慶民、王政騰、梁逸。1985。台灣南部地區生羊乳理化性狀之研究。畜產研究18 (2) : 175-183。 Ahmed, A. S., T. El-Bassiony, L. M. Elmalt, and H. R. Ibrahim. 2015. Identification of potent antioxidant bioactive peptides from goat milk proteins. Food Research International 74:80-88. Alferez, M. J., M. Barrionuevo, I. Lopez Aliaga, M. R. Sanz-Sampelayo, F. Lisbona, J. C. Robles, and M. S. Campos. 2001. Digestive utilization of goat and cow milk fat in malabsorption syndrome. The Journal of Dairy Research 68(3):451-461. Araújo, D. F. d. S., G. C. B. Guerra, R. F. d. A. Júnior, A. Antunes de Araújo, P. O. Antonino de Assis, A. Nunes de Medeiros, Y. R. Formiga de Sousa, M. M. E. Pintado, J. Gálvez, and R. d. C. R. d. E. Queiroga. 2016. Goat whey ameliorates intestinal inflammation on acetic acid-induced colitis in rats. Journal of Dairy Science 99(12):9383-9394. Ardizzone, S., G. Maconi, A. Russo, V. Imbesi, E. Colombo, and G. Bianchi Porro. 2006. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut 55(1):47. Assis, P. O. A. d., G. C. B. Guerra, D. F. d. S. Araújo, R. F. d. Araújo Júnior, T. A. D. G. Machado, A. A. d. Araújo, T. A. S. d. Lima, H. E. M. Garcia, L. d. F. L. I. d. Andrade, and R. d. C. R. d. E. Queiroga. 2016. Intestinal anti-inflammatory activity of goat milk and goat yoghurt in the acetic acid model of rat colitis. International Dairy Journal 56:45-54. Attaie, R. and R. L. Richter. 2000. Size distribution of fat globules in goat milk. Journal of Dairy Science 83(5):940-944. Bermudez-Brito, M., J. Plaza-Diaz, L. Fontana, S. Munoz-Quezada, and A. Gil. 2013. In vitro cell and tissue models for studying host-microbe interactions: a review. The British Journal of Nutrition 109 Suppl 2:S27-34. Biasi, F., G. Leonarduzzi, P. I. Oteiza, and G. Poli. 2013. Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets. Antioxidants & Redox Signaling 19(14):1711-1747. Brown, K. D. and D. M. Blakeley. 1983. Cell growth-promoting activity in mammary secretions of the goat, cow and sheep. The British Veterinary Journal 139(1):68-78. Campbell, J.R., and R.T. Marshall. 1975. The Science of Providing Milk for Man. In McGraw-Hill Book (pp. 801). Academic Press, NY, USA. Carles, C. 1986. Fractionation of bovine caseins by reverse phase high performance liquid chromatography: identification of a genetic variant. The Journal of Dairy Research 53(1):35-41. Carpenter, G. 1980. Epidermal growth factor is a major growth-promoting agent in human milk. Science 210(4466):198-199. Cencič, A. and T. Langerholc. 2010. Functional cell models of the gut and their applications in food microbiology - a review. International Journal of Food Microbiology 141 Suppl 1:S4-14. Chen, Y. P., P. J. Hsiao, W. S. Hong, T. Y. Dai, and M. J. Chen. 2012. Lactobacillus kefiranofaciens M1 isolated from milk kefir grains ameliorates experimental colitis in vitro and in vivo. Journal of Dairy Science 95(1):63-74. Cook, M. E., C. C. Miller, Y. Park, and M. Pariza. 1993. Immune modulation by altered nutrient metabolism: nutritional control of immune-induced growth depression. Poultry Science 72(7):1301-1305. Crozier, G., B. Bois-Joyeux, M. Chanez, J. Girard, and J. Peret. 1987. Metabolic effects induced by long-term feeding of medium-chain triglycerides in the rat. Metabolism 36(8):807-814. Daddaoua, A., V. Puerta, P. Requena, A. Martinez-Ferez, E. Guadix, F. S. de Medina, A. Zarzuelo, M. D. Suarez, J. J. Boza, and O. Martinez-Augustin. 2006. Goat milk oligosaccharides are anti-inflammatory in rats with hapten-induced colitis. Journal of Nutrition 136(3):672-676. De Boissieu, D., J. Badoual, C. Dupont, S. Chaussade, Y. Denizot, and J. Benveniste. 1991. Study of platelet-activating factor (PAF) in stools of newborn infants with hemorrhagic colitis. Archives Francaises de Pediatrie 48(7):515. Debski, B., M. F. Picciano, and J. A. Milner. 1987. Selenium content and distribution of human, cow and goat milk. The Journal of Nutrition 117(6):1091-1097. Dehlink, E., K. J. Domig, C. Loibichler, E. Kampl, T. Eiwegger, A. Georgopoulos, W. Kneifel, R. Urbanek, and Z. Szepfalusi. 2007. Heat- and formalin-inactivated probiotic bacteria induce comparable cytokine patterns in intestinal epithelial cell-leucocyte cocultures. Journal of Food Protection 70(10):2417-2421. Dehnhard, M., R. Claus, O. Munz, and U. Weiler. 2000. Course of epidermal growth factor (EGF) and insulin-like growth factor I (IGF-I) in mammary secretions of the goat during end-pregnancy and early lactation. Journal of Veterinary Medicine 47(9):533-540. El-Salam, M. H. A. and S. El-Shibiny. 2013. Bioactive peptides of buffalo, camel, goat, sheep, mare, and yak milks and milk products. Food Reviews International 29(1):1-23. FAO, 2013. Production Yearbook 2013. Food and Agriculture Organization of the United Nations, vol. 48. Statistical Series No.156, Rome, Italy, p. 251. Frøslie, K. F., J. Jahnsen, B. A. Moum, and M. H. Vatn. 2007. Mucosal healing in inflammatory bowel disease: results from a norwegian population-based cohort. Gastroenterology 133(2):412-422. Francescone, R., V. Hou, and S. I. Grivennikov. 2015. Cytokines, IBD, and colitis-associated cancer. Inflammatory Bowel Diseases 21(2):409-418. Furukawa, M., E. L. Lee, and J. M. Johnston. 1993a. Platelet-activating factor–induced ischemic bowel necrosis: the effect of platelet-activating factor acetylhydrolase. Pediatric Research 34(2):237. Furukawa, M., H. Narahara, K. Yasuda, and J. M. Johnston. 1993b. Presence of platelet-activating factor-acetylhydrolase in milk. Journal of Lipid Research 34(9):1603-1609. Gálvez, J., M. Comalada, and J. Xaus. 2010. Prebiotics and probiotics in experimental models of rodent colitis: lessons in treatment or prevention of inflammatory bowel diseases. In R. R. Watson, V. R. Preedy (Eds.), Bioactive Foods in Promoting Health (pp. 589-610). Academic Press, Oxford, UK. Gibson, P. and O. Rosella. 1995. Interleukin 8 secretion by colonic crypt cells in vitro: response to injury suppressed by butyrate and enhanced in inflammatory bowel disease. Gut 37(4):536-543. Grosvenor, C. E., M. F. Picciano, and C. R. Baumrucker. 1993. Hormones and growth factors in milk. Endocrine Reviews 14(6):710-728. Haenlein, G. F. W. and R. Caccese. 1984. Goat milk versus cow milk. In Haenlein, G.F.W., Ace, D.L. (Eds.), Extension Goat Handbook. USDA Publ., Washington, DC. Haenlein, G. F. W. 2004. Goat milk in human nutrition. Small Ruminant Research 51(2):155-163. Hubatsch, I., E. G. Ragnarsson, and P. Artursson. 2007. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nature Protocols 2(9):2111-2119. Jenness, R. 1980. Composition and characteristics of goat milk: review. Journal of Dairy Science 63(10):1605-1630. Jirillo, F., G. Martemucci, A. G. D'Alessandro, M. A. Panaro, A. Cianciulli, M. Superbo, E. Jirillo, and T. Magrone. 2010. Ability of goat milk to modulate healthy human peripheral blood lymphomonocyte and polymorphonuclear cell function: in vitro effects and clinical implications. Current Pharmaceutical Design 16(7):870-876. Kaplan, G. G. 2015. The global burden of IBD: from 2015 to 2025. Nature Reviews. Gastroenterology & Hepatology 12(12):720-727. Kim, D. H. and J. H. Cheon. 2017. Pathogenesis of inflammatory bowel disease and recent advances in biologic therapies. Immune Network 17(1):25-40. Konturek, J. W., T. Brzozowski, and S. J. Konturek. 1991. Epidermal growth factor in protection, repair, and healing of gastroduodenal mucosa. Journal of Clinical Gastroenterology 13:S88-97. Korhonen, H. and A. Pihlanto. 2003. Food-derived bioactive peptides-opportunities for designing future foods. Current Pharmaceutical Design 9(16):1297-1308. Kuo, C. J., K. H. Yu, L. C. See, C. T. Chiu, M. Y. Su, C. M. Hsu, C. F. Kuo, M. J. Chiou, J. R. Liu, and H. W. Wang. 2015. The trend of inflammatory bowel diseases in Taiwan: A population-based study. Digestive Diseases and Sciences 60(8):2454-2462. Lahov, E. and W. Regelson. 1996. Antibacterial and immunostimulating casein-derived substances from milk: Casecidin, isracidin peptides. Food and Chemical Toxicology 34(1):131-145. Lara-Villoslada, F., E. Debras, A. Nieto, A. Concha, J. Gálvez, E. López-Huertas, J. Boza, C. Obled, and J. Xaus. 2006. Oligosaccharides isolated from goat milk reduce intestinal inflammation in a rat model of dextran sodium sulfate-induced colitis. Clinical Nutrition 25(3):477-488. Lavigne, C., J. A. Zee, R. E. Simard, and B. Béliveau. 1989. Effect of processing and storage conditions on the fate of vitamins B1, B2, and C and on the shelf-life of goat's milk. Journal of Food Science 54(1):30-34. Lawless, F., J. J. Murphy, D. Harrington, R. Devery, and C. Stanton. 1998. Elevation of conjugated cis-9, trans-11-octadecadienoic acid in bovine milk because of dietary supplementation. Journal of Dairy Science 81(12):3259-3267. Lennard-Jones, J. E. 1989. Classification of inflammatory bowel disease. Scandinavian Journal of Gastroenterology. Supplement 170:2-6; discussion 16-19. Li, J., T. Moran, E. Swanson, C. Julian, J. Harris, D. K. Bonen, M. Hedl, D. L. Nicolae, C. Abraham, and J. H. Cho. 2004. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations. Human Molecular Genetics 13(16):1715-1725. Lucas, A. and T. Cole. 1990. Breast milk and neonatal necrotising enterocolitis. The Lancet 336(8730-8731):1519-1523. M’Koma, A. E. 2013. Inflammatory Bowel Disease: An expanding global health problem. Clinical medicine insights. Gastroenterology 6:33-47. Magalhães, J., F. D. d. Castro, P. B. Carvalho, J. F. Machado, S. Leite, M. J. Moreira, and J. Cotter. 2015. Disability in inflammatory bowel disease: translation to portuguese and validation of the “inflammatory bowel disease – disability score”. Portuguese Journal of Gastroenterology 22(1):4-14. Mazzucchelli, L., C. Hauser, K. Zgraggen, H. Wagner, M. Hess, J. A. Laissue, and C. Mueller. 1994. Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. The American Journal of Pathology 144(5):997-1007. Mikkelsen, J., P. Højrup, and J. Knudsen. 2009. Purification of goats' milk casein by reversed-phase high-performance liquid chromatography and identification of αs1-casein. Journal of Dairy Research 54(3):361-367. Mitsuyama, K., A. Toyonaga, E. Sasaki, K. Watanabe, H. Tateishi, T. Nishiyama, T. Saiki, H. Ikeda, O. Tsuruta, and K. Tanikawa. 1994. IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease. Clinical and Experimental Immunology 96(3):432-436. Molodecky, N. A., I. S. Soon, D. M. Rabi, W. A. Ghali, M. Ferris, G. Chernoff, E. I. Benchimol, R. Panaccione, S. Ghosh, H. W. Barkema, and G. G. Kaplan. 2012. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142(1):46-54.e42; quiz e30. Morand-Fehr, P., J. P. Boutonnet, C. Devendra, J. P. Dubeuf, G. F. W. Haenlein, P. Holst, L. Mowlem, and J. Capote. 2004. Strategy for goat farming in the 21st century. Small Ruminant Research 51(2):175-183. Nehir El, S., S. Karakaya, S. Simsek, D. Dupont, E. Menfaatli, and A. T. Eker. 2015. In vitro digestibility of goat milk and kefir with a new standardised static digestion method (INFOGEST cost action) and bioactivities of the resultant peptides. Food & Function 6(7):2322-2330. Neurath, M. F. 2014. Cytokines in inflammatory bowel disease. Nature Reviews. Immunology 14(5):329-342. Nishimura, M., Y. Kuboi, K. Muramoto, T. Kawano, and T. Imai. 2009. Chemokines as novel therapeutic targets for inflammatory bowel disease. Annals of the New York Academy of Sciences 1173:350-356. Nishimura, S., N. Maeno, K. Matsuo, T. Nakajima, I. Kitajima, H. Saito, and I. Maruyama. 2002. Human lactiferous mammary gland cells produce vascular endothelial growth factor (VEGF) and express the VEGF receptors, Flt-1 and KDR/Flk-1. Cytokine 18(4):191-198. O’ Connell, J. E. and P. F. Fox. 2011. Heat treatment of milk: Heat stability of milk. In J. W. Fuquay (Eds.), Encyclopedia of Dairy Sciences (pp. 744-749). Academic Press, San Diego, CA. Park, Y. W. 2008. Goat milk‐chemistry and nutrition. In Y. W. Park and G. F. Haenlein (Eds.), Handbook of Milk of Non‐Bovine Mammals (pp. 34-58). Blackwell Publishing, Ames, IO, USA. Park, Y. W. and H. I. Chukwu. 1988. Macro-mineral concentrations in milk of two goat breeds at different stages of lactation. Small Ruminant Research 1(2):157-166. Park, Y. W., M. Juárez, M. Ramos, and G. F. W. Haenlein. 2007. Physico-chemical characteristics of goat and sheep milk. Small Ruminant Research 68(1):88-113. Park, Y. W. and M. S. Nam. 2015. Bioactive Peptides in Milk and Dairy Products: A Review. Korean Journal for Food Science of Animal Resources 35(6):831-840. Perse, M. and A. Cerar. 2012. Dextran sodium sulphate colitis mouse model: traps and tricks. Journal of Biomedicine & Biotechnology 2012:718617. Playford, R. J., C. E. Macdonald, and W. S. Johnson. 2000. Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders. The American Journal of Clinical Nutrition 72(1):5-14. Posati, L. P. and M. L. Orr. 1976. Composition of foods: dairy and egg products - raw, processed, prepared. Agricultural Handbook No. 8-1 (pp. 77-109). ARS, USDA, Washington, DC., USA. Puccio, F. and T. Lehy. 1988. Oral administration of epidermal growth factor in suckling rats stimulates cell DNA synthesis in fundic and antral gastric mucosae as well as in intestinal mucosa and pancreas. Regulatory Peptides 20(1):53-64. Riddell, R. H., H. Goldman, D. F. Ransohoff, H. D. Appelman, C. M. Fenoglio, R. C. Haggitt, C. Ahren, P. Correa, S. R. Hamilton, B. C. Morson, S. C. Sommers, and J. H. Yardley. 1983. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Human Pathology 14(11):931-968. Rival, S. G., C. G. Boeriu, and H. J. Wichers. 2001a. Caseins and casein hydrolysates. 2. Antioxidative properties and relevance to lipoxygenase inhibition. Journal of Agricultural and Food Chemistry 49(1):295-302. Rival, S. G., S. Fornaroli, C. G. Boeriu, and H. J. Wichers. 2001b. Caseins and casein hydrolysates. 1. Lipoxygenase inhibitory properties. Journal of Agricultural and Food Chemistry 49(1):287-294. Rutgeerts, P., R. H. Diamond, M. Bala, A. Olson, G. R. Lichtenstein, W. Bao, K. Patel, D. C. Wolf, M. Safdi, J. F. Colombel, B. Lashner, and S. B. Hanauer. 2006. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. Gastrointestinal Endoscopy 63(3):433-442. Rutter, M. D., B. P. Saunders, K. H. Wilkinson, S. Rumbles, G. Schofield, M. A. Kamm, C. B. Williams, A. B. Price, I. C. Talbot, and A. Forbes. 2004. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut 53(12):1813. Rysstad, G., W. J. Knutsen, and R. K. Abrahamsen. 2009. Effect of threonine and glycine on acetaldehyde formation in goats' milk yogurt. Journal of Dairy Research 57(3):401-411. Sambuy, Y., I. De Angelis, G. Ranaldi, M. L. Scarino, A. Stammati, and F. Zucco. 2005. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biology and Toxicology 21(1):1-26. Sang, L. X., B. Chang, C. Dai, N. Gao, W. X. Liu, and M. Jiang. 2013. Heat-killed VSL#3 ameliorates dextran sulfate sodium (DSS)-induced acute experimental colitis in rats. International Journal of Molecular Sciences 15(1):15-28. Satsu, H., T. Matsuda, T. Toshimitsu, A. Mori, T. Mae, M. Tsukagawa, M. Kitahara, and M. Shimizu. 2004. Regulation of interleukin-8 secretion in human intestinal epithelial Caco-2 cells by α-humulene. Biofactors 21(1-4):137-139. Schnitzler, F., H. Fidder, M. Ferrante, M. Noman, I. Arijs, G. Van Assche, I. Hoffman, K. Van Steen, S. Vermeire, and P. Rutgeerts. 2009. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease. Inflammatory Bowel Diseases 15(9):1295-1301. Shen, C. R., C. L. Liu, H. P. Lee, and J. K. Chen. 2013. The identification and characterization of chitotriosidase activity in pancreatin from porcine pancreas. Molecules 18(3):2978-2987. Silanikove, N., G. Leitner, U. Merin, and C. G. Prosser. 2010. Recent advances in exploiting goat's milk: Quality, safety and production aspects. Small Ruminant Research 89(2):110-124. Solomon, L., S. Mansor, P. Mallon, E. Donnelly, M. Hoper, M. Loughrey, S. Kirk, and K. Gardiner. 2010. The dextran sulphate sodium (DSS) model of colitis: an overview. Comparative Clinical Pathology 19(3):235-239. Strober, W. and I. J. Fuss. 2011. Pro-Inflammatory Cytokines in the Pathogenesis of IBD. Gastroenterology 140(6):1756-1767. Suetsuna, K., H. Ukeda, and H. Ochi. 2000. Isolation and characterization of free radical scavenging activities peptides derived from casein. The Journal of Nutritional Biochemistry 11(3):128-131. Sung, Y. Y., T. I. Wu, and P. H. Wang. 1999. Evaluation of milk quality of Alpine, Nubian, Saanen and Toggenburg breeds in Taiwan. Small Ruminant Research 33(1):17-23. Thornberry, N. A., H. G. Bull, J. R. Calaycay, K. T. Chapman, A. D. Howard, M. J. Kostura, D. K. Miller, S. M. Molineaux, J. R. Weidner, and J. Aunins. 1992. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356(6372):768-774. Tsao, P., T. Kuo, J. Hsu, L. Chow, and F. Wu. 2007. Cloning, expression and antibody production of caprine platelet-activating factor acetylhydrolase. Journal of Dairy Science 90 (suppl. 1). Turner, M. D., B. Nedjai, T. Hurst, and D. J. Pennington. 2014a. Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1843(11):2563-2582. Turner, M. D., B. Nedjai, T. Hurst, and D. J. Pennington. 2014b. Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochimica et Biophysica Acta 1843(11):2563-2582. Ustunol, Z. and C. Wong. 2010. Effect of nonfat dry milk and major whey components on interleukin-6 and interleukin-8 production in human intestinal epithelial-like Caco-2 cells. Journal of Dairy Science 93(6):2311-2314. Vongsa, R. A., N. P. Zimmerman, and M. B. Dwinell. 2009. CCR6 regulation of the actin cytoskeleton orchestrates human beta defensin-2- and CCL20-mediated restitution of colonic epithelial cells. The Journal of Biological Chemistry 284:10034–10045. Walsh, A., R. Palmer, and S. Travis. 2014. Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activity. Gastrointestinal Endoscopy Clinics of North America 24(3):367-378. Wirtz, S., C. Neufert, B. Weigmann, and M. F. Neurath. 2007. Chemically induced mouse models of intestinal inflammation. Nature Protocols 2(3):541-546. Wu, F. and T. Elsasser. 1995. Studies on cell growth promoting activity in goat milk. Journal of the Chinese Agricultural Chemical Society 33:326-326. Wu, F. Y., P. H. Tsao, D. C. Wang, S. Lin, J. Wu, and Y. K. Cheng. 2006. Factors Affecting Growth Factor Activity in Goat Milk. Journal of Dairy Science 89(6):1951-1955. Yadav, A. K., J. Singh, and S. K. Yadav. 2016. Composition, nutritional and therapeutic values of goat milk: A review. Asian Journal of Dairy and Food Research 35(2). Yamada, Y., S. Saito, and H. Morikawa. 1998. Hepatocyte growth factor in human breast milk. American Journal of Reproductive Immunology (New York, N.Y. : 1989) 40(2):112-120. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/70480 | - |
dc.description.abstract | 發炎性腸道疾病 (Inflammatory bowel disease, IBD) 是一種結腸和小腸的慢性發炎。在已開發國家,IBD具有高發生率及高盛行率的特性,而目前的治療方針對於IBD病患的治療效果尚不夠理想;因此,受限於現有的藥物治療所造成的副作用或其成效不彰,有效的食品輔助療法則顯得十分重要。過去的研究顯示,羊乳具有預防腸道發炎的潛力。因此,本研究的目的旨在評估不同來源與殺菌條件之台灣國產羊乳在腸道抗發炎的效果,並進一步分析羊乳中何種蛋白質成分對腸道發炎具有最佳之生物活性。
我們自台灣本土市售羊乳取得三種不同品牌來源,並分別進行不同的熱殺菌條件,分為四個組別:品牌A的高溫短時間殺菌法 (high-temperature short-time, HTST) (A-H)、品牌B的HTST (B-H) 和低溫長時間殺菌法 (low-temperature long-time, LTLT) (B-L),以及品牌C的超高溫瞬間殺菌法 (ultra-high temperature, UHT) (C-U)。首先,以人類腸道上皮結腸癌細胞株Caco-2於葡聚糖硫酸鈉 (dextran sodium sulfate, DSS) 有無的試驗條件下,評估不同乳源及殺菌條件之羊乳的抗發炎活性。在細胞存活率的試驗結果中,所有處理組對Caco-2細胞皆不具有細胞毒性,且不論在預處理的共培養後或DSS所造成的細胞傷害下,各組皆具有促進Caco-2細胞存活率並抵抗DSS對細胞傷害的效果。接著,測量極化的腸道上皮細胞Caco-2單層膜的跨膜上皮電阻 (transepithelial electrical resistance, TEER) 值,觀察各處理組對腸道上皮屏障功能之效果。結果顯示,在預處理的48小時共培養後,羊乳A-H和C-U能使TEER值提升,而各處理組在DSS造成Caco-2單層膜受損時,皆能有效減緩DSS引起之TEER值的降低。亦即羊乳具有加強腸道上皮細胞完整性及其屏障功能的能力,進而預防或抵抗腸道上皮細胞通透性的增加。 此外,CCL20為一種腸道上皮修復的趨化因子,我們發現處理組A-H能有效促進Caco-2細胞生成CCL20,並在DSS造成Caco-2細胞受損時,維持CCL20的生成量。此外,我們也發現羊乳A-H能促使Caco-2細胞生成促發炎激素IL-8,其為嗜中性顆粒球的趨化因子;而在DSS傷害下,各處理組皆具有維持Caco-2細胞分泌IL-8之特性。因此,取自不同乳源及殺菌條件的各處理組中,以羊乳A-H在腸道抗發炎上具有最佳之效果,是以該組進行後續的試驗。 為了進一步探討羊乳中有效的抗發炎成分之所在,我們將羊乳蛋白質分離為酪蛋白與乳清蛋白,並發酵羊乳之kefir,再以模擬消化液進行水解。在細胞存活率的試驗中,消化後的全乳 (dW) 和消化後的酪蛋白 (dC) 最具細胞保護效果。而所有處理組皆可在DSS的細胞傷害下維持TEER值。另外,我們發現dC在DSS造成的細胞傷害下,仍具有促進Caco-2細胞生成CCL20和IL-8的能力。因此,我們進一步以dC分析其潛在之機能性成分。 利用十二烷基硫酸鈉聚丙烯醯胺凝膠電泳 (SDS-PAGE) 分析羊乳A-H消化前後之全乳與酪蛋白之蛋白質分子量與其圖譜差異。結果顯示,羊乳蛋白質在消化後被水解成較小之片段,使消化後許多蛋白質條帶消失,而消化後的一些胜肽片段在未消化的組別中並不存在。 綜上所述,本研究體外試驗之成果證明台灣國產羊乳具有維持腸道細胞恆定功能與抗腸道發炎之潛力,未來需進一步以動物實驗證實體外試驗之結果。 | zh_TW |
dc.description.abstract | Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the colon and small intestine. With high incidence and prevalence of IBD in developed countries, lots of patients with IBD still do not show an appropriate response to existing therapies; therefore, instead of pharmacological therapy with side effects and high rate of treatment failure, the importance of effective dietary supplementation can’t be overemphasized. Several studies revealed that goat milk had potential preventive effects on intestinal inflammatory injury. Therefore, the aim of this study is to evaluate the intestinal anti-inflammatory effect of local goat milk from various origins with different pasteurized conditions, and further explore which protein fractions in goat milk has the best biological effect on inflammatory damages.
Three brands of goat milk products with different thermal processes were used and divided into four groups, brand A with high-temperature short-time (HTST) (A-H), brand B with HTST (B-H) and low-temperature long-time (LTLT) (B-L), and brand C with ultra-high temperature (C-U). The effect of goat milk samples from different brands with specific thermal processes on their anti-inflammatory effect were evaluated using Caco-2 cells with or without dextran sodium sulfate (DSS). MTT assay results indicated that all the treatments showed no cytotoxicity to Caco-2 cells, and were effective in protecting cells against DSS-induced damage. We further measured the transepithelial electrical resistance (TEER) value to evaluate the effect of treatments on intestinal epithelial monolayer. Treatment of A-H and C-U enhanced TEER value after 48 hours co-culture. Further, pre-treatment of all groups could protect Caco-2 intestinal epithelial monolayer against DSS-induced loss of barrier function. In addition, we measured the level of CCL20, an intestinal epithelial restitution and migration chemokine. CCL20 was upregulated by the groups A-H with or without DSS treatment. IL-8, a neutrophil-attracting chemokine, was upregulated by A-H without DSS treatment; on the other hand, all treatments could upregulate the level of IL-8. Based on the above results, we selected A-H group for the following study. To further investigate which components of goat milk involving in the anti-inflammatory effect, we separated goat milk into casein and whey protein, and further hydrolyzed by in vitro digestion. Meanwhile, the goat milk kefir was also used for comparison. MTT assay results indicated that all the treatments showed no cytotoxicity to Caco-2 cells. Under DSS-induced damage condition, digested whole goat milk (dW) and digested casein (dC) were more effective in protecting cells. TEER values were restored by all treatments after treating DSS. Additionally, we found that digested casein could upregulate CCL20 and IL-8 levels with DDS damage. Thus, we selected digested casein to investigate the potential functional compounds. We further analyzed the protein profile of undigested and digested goat milk and goat milk casein by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) to estimate their molecular weight and characterize those proteins. Goat milk proteins were hydrolyzed to smaller fragments after in vitro digestion with disappearance of several proteins bands. The findings of this study prove the potential intestinal anti-inflammatory activity of Taiwan goat milk in sustaining intestinal homeostasis in various aspects. Further animal study is necessary to confirm the in vitro results. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T04:29:07Z (GMT). No. of bitstreams: 1 ntu-107-R05626006-1.pdf: 4866588 bytes, checksum: 793700b5c32b3bd89c64ad60cdabbe09 (MD5) Previous issue date: 2018 | en |
dc.description.tableofcontents | 致謝 i
序言 iii 中文摘要 iv Abstract vi 壹、文獻探討 1 第一節:山羊乳之介紹 1 一、山羊與山羊乳 1 二、羊乳主要成分 2 三、不同山羊品種間之組成分 7 四、不同殺菌條件對羊乳成分之影響 7 五、羊乳之機能性及其成分 12 第二節:發炎性腸道疾病之簡介 (Inflammatory bowel disease, IBD) 18 一、發炎性腸道疾病 18 二、發炎性腸道疾病的症狀 21 三、發炎性腸道疾病的致病原因 22 四、發炎性腸道疾病的治療 22 五、腸道屏障功能與結腸炎之相關研究 24 貳、材料與方法 30 一、國產羊乳之製備 31 (一) 試驗材料 31 (二) 試驗方法 31 二、Caco-2 細胞之活化與保存 32 (一) 試驗材料 32 (二) 試驗方法 33 三、Caco-2 細胞與羊乳樣品共培養 34 (一) 試驗材料 34 (二) 試驗方法 34 四、探討國產羊乳樣品對Caco-2細胞存活率之影響 35 (一) 試驗材料 35 (二) 試驗方法 35 五、探討國產羊乳對腸道上皮屏障功能完整性之影響 36 (一) 試驗材料 36 (二) 試驗方法 36 六、探討國產羊乳對Caco-2細胞免疫調節能力之影響 36 (一) 試驗材料 36 (二) 試驗方法 37 七、國產羊乳中可能有效成分之鑑定 37 (一) 試驗材料 37 (二) 試驗方法 37 八、統計分析 39 参、結果 43 一、探討不同乳源與殺菌條件之國產羊乳對腸道上皮細胞之影響 43 (一) 不同乳源與殺菌條件之國產羊乳粗蛋白測定 43 (二) 細胞存活率試驗 43 (三) 跨膜上皮電阻值試驗 44 (四) Caco-2細胞分泌之趨化因子CCL20及細胞激素IL-8濃度之測定 45 二、探討國產羊乳於消化前後之不同蛋白質片段對腸道上皮細胞之影響 54 (一) 國產羊乳於消化前後之不同蛋白質片段之蛋白質濃度測定 54 (二) 細胞存活率試驗 54 (三) 跨膜上皮電阻值試驗 55 (四) Caco-2細胞分泌之趨化因子CCL20及細胞激素IL-8濃度之測定 56 三、國產羊乳可能有效成分之鑑定 65 (一) SDS-PAGE 蛋白質電泳分析 65 肆、討論 67 伍、結論 73 陸、參考文獻 75 | |
dc.language.iso | zh-TW | |
dc.title | 藉由體外試驗評估國產羊乳對腸道抗發炎之效果 | zh_TW |
dc.title | Evaluation of Taiwan goat milk on its intestinal anti-inflammatory effect in vitro | en |
dc.type | Thesis | |
dc.date.schoolyear | 106-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 劉?睿(Je-Ruei Liu),陳彥伯(Yen-Po Chen),王聖耀(Sheng-Yao Wang),郭卿雲(Ching-Yun Kuo) | |
dc.subject.keyword | 台灣羊乳,乳蛋白質,殺菌條件,體外消化,腸道抗發炎, | zh_TW |
dc.subject.keyword | Taiwan goat milk,milk protein,pasteurized conditions,in vitro digestion,intestinal anti-inflammatory, | en |
dc.relation.page | 86 | |
dc.identifier.doi | 10.6342/NTU201803128 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2018-08-13 | |
dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
dc.contributor.author-dept | 動物科學技術學研究所 | zh_TW |
顯示於系所單位: | 動物科學技術學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-107-1.pdf 目前未授權公開取用 | 4.75 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。